Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 200,000 shares at $89.48 ($17.6M) on 2025-08-14, disclosed to the SEC on 2025-08-18.
Open-market sale of $17.6M ANIP by HEAD OF R&D, COO-NOVITIUM Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.48 | 47,010 | $4.2M | 23.8% |
| 2 | $89.48 | 47,010 | $4.2M | 23.8% |
| 3 | $87.15 | 52,990 | $4.6M | 26.2% |
| 4 | $87.15 | 52,990 | $4.6M | 26.2% |
| Total | $88.25 avg | 200,000 | $17.6M | 100% |
| Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |
| ANIP | SELL | 2024-06-24 | $1.2M | — | Filing → |